PlA2 polymorphism and efficacy of aspirin
- 1 April 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 351 (9111) , 1253
- https://doi.org/10.1016/s0140-6736(05)79320-x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Association of the Platelet Pl A Polymorphism of Glycoprotein IIb/IIIa and the Fibrinogen Bβ 448 Polymorphism With Myocardial Infarction and Extent of Coronary Artery DiseaseCirculation, 1997
- PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosisThe Lancet, 1997
- A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary ThrombosisNew England Journal of Medicine, 1996
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994